Skip to content
10-Q

Quarterly Report

Instil Bio, Inc. TIL

0001789769-25-000051

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 6.56M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $15.37M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $8.81M
Current Liabilities Q1 2025 · Mar 31, 2025 $7.23M
Current Liabilities Q1 2025 · Dec 31, 2024 $7.9M
Total Liabilities Q1 2025 · Mar 31, 2025 $92.54M
Total Liabilities Q1 2025 · Dec 31, 2024 $94.13M
Current Assets Q1 2025 · Mar 31, 2025 $219.26M
Current Assets Q1 2025 · Dec 31, 2024 $124.47M
Total Assets Q1 2025 · Mar 31, 2025 $237.45M
Total Assets Q1 2025 · Dec 31, 2024 $263.57M
Shares Diluted Q1 2025 · Mar 31, 2024 6.5M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$14.39M
Stockholders Equity Q1 2025 · Mar 31, 2024 $205.83M
Stockholders Equity Q1 2025 · Dec 31, 2023 $225.83M
Eps Diluted Q1 2025 · Mar 31, 2024 −$3.74
Eps Basic Q1 2025 · Mar 31, 2024 −$3.74
Sga Expense Q1 2025 · Mar 31, 2024 $12.42M
Net Income Q1 2025 · Mar 31, 2024 −$24.3M
Operating Income Q1 2025 · Mar 31, 2024 −$23.96M